Tests two clot-removal devices versus one in acute ischemic stroke
Tests using two stentrievers at once against one, in adults with acute ischemic stroke.
Plain-language title generated from the registry record
Registry title: Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke
Key facts
- Where
- Barakaldo, Oviedo, and Valladolid, SpainSee the 3 sites
Where in Spain
- Hospital Universitario de CrucesBarakaldo, SpainTaking people
- Hospital Universitario Central De AsturiasOviedo, SpainTaking people
- Hospital Clínico Universitario de ValladolidValladolid, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fundación EPIC
- Trial code
- NCT05930145
- Record updated
- 28 July 2025
- Original description
Several studies have demonstrated that simultaneous treatment with two stentrievers (STs) as rescue treatment is very effective, with high recanalization rates even in this group of patients where other revascularization techniques have failed. There has been no observed increase in hemorrhagic complications. Recently, a prospective study has been published where treatment with two ST has been shown to be effective and safe if used as a first-choice treatment (not as rescue) with a successful recanalization rate (eTICI 2c/3) after the first pass of 69%. These results have been reinforced after the publication of a randomized study that confirms, in vitro, the superiority of using two ST over one.Read full original descriptionShow less
A Randomized Study Comparing the Effectiveness and Security of the Use of Two Stentrievers Simultaneously Versus One Stentriever as a Primary Treatment in Acute Ischemic Stroke Patients.
Several studies have demonstrated that simultaneous treatment with two stentrievers (STs) as rescue treatment is very effective, with high recanalization rates even in this group of patients where other revascularization techniques have failed. There has been no observed increase in hemorrhagic complications. Recently, a prospective study has been published where treatment with two ST has been shown to be effective and safe if used as a first-choice treatment (not as rescue) with a successful recanalization rate (eTICI 2c/3) after the first pass of 69%. These results have been reinforced after the publication of a randomized study that confirms, in vitro, the superiority of using two ST over one.
Inclusion: A new disabling focal neurological deficit compatible with acute cerebral ischemia; Any age. Informed consent obtained from the patient or representative; NIHSS score ≥ 6; Pre-existing functional clinical status less than or equal to 2 according to the mRS clinical scale; Maximum time of 24 hours from symptom onset to arterial puncture. • TICI 0-1 in the diagnosed TICA (terminal internal carotid artery) , MCA (middle cerebral artery), and BA( basilar artery confirmed by angioCT and angiography); ASPECTs score on baseline CT greater than or equal to 6; In cases where it is indicated, prior intravenous fibrinolysis will be administered according to the protocols of each center.
Exclusion: Initiation of treatment with a different technique than the one described; Advanced or terminal disease with a life expectancy of less than 6 months; Evidence of significant hemorrhage or mass effect with midline shift on baseline CT; Those described in the usual protocols for mechanical thrombectomy of each hospital; Pre-existing functional clinical status greater than 2 according to the mRS clinical scale; Patients with tandem lesions of dissection or arteriosclerotic origin located in the extracranial internal carotid artery; Inability to use a proximal balloon guide catheter; Use of aspiration catheter; Intracranial atherosclerotic plaque as the cause of occlusion; Patient who is participating in another study that may affect this one; ASPECTS score less than or equal to 6 on baseline CT; Patients with occlusions in multiple vascular territories; Evidence of intracranial tumor (except for small meningiomas).